MedTrace Logo

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

NCT05908708 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-04-09

No results posted yet for this study

Summary

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.

Conditions

Interventions

DEVICE

Medtronic 780G® hybrid closed loop

Medtronic 780G® hybrid closed loop system uses the commercial "auto-mode" with an insulin pump and continuous glucose monitoring.

Sponsors & Collaborators

  • Tel-Aviv Sourasky Medical Center

    collaborator OTHER_GOV

  • Maccabi Healthcare Services, Israel

    collaborator OTHER

  • Wolfson Medical Center

    collaborator OTHER_GOV

  • Assaf-Harofeh Medical Center

    collaborator OTHER_GOV

  • Sheba Medical Center

    lead OTHER_GOV

Eligibility

Min Age
1 Year
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2026-07-01
Completion
2026-07-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05908708 on ClinicalTrials.gov